Eucope Visual

EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs

Conferences and next Working Groups

  • 9 October 2014: EUCOPE Board Meeting in Brussels

Payers’ Forum Europe

1 – 2 October in Berlin

Payers Forum Europe 2014

The Payers’ Forum Europe will put you infront of Payers and HTA directors from across Europe as they explain their processes, updates and examples of engagement. You will be engaged in direct, yet open discussion with senior European Payers, HTA bodies and Regulators.

Please find more information on the event hosted on 1 – 2 October in Berlin here.

Welcome!

EUCOPE provides a platform for discussion for pharmaceutical entrepreneurs. On a regular basis owners and CEOs of pharmaceutical companies and associations discuss solutions to improve the quality of life for patients and to strengthen the competitiveness of the European pharmaceutical industry.

The legal framework for pharmaceutical markets is set largely by the EU institutions. An active role in the political debate on the EU level is therefore more important than ever before. The early perception of future markets and reliable regulatory circumstances are key aspects for entrepreneurial success.

Knowledge about this legal framework and the active discussion and participation on the EU level is therefore essential for pharmaceutical entrepreneurs in order to generate innovations.

EU Flag

Our services

EUCOPE understands itself as service provider for its members. The association provides its members with an early understanding about regulatory developments.

Current regulatory topics are:

A tight monitoring and comprehensive information about future market conditions are valuable assets for entrepreneurial decisions. Questions such as access to finance, market access and reliable reimbursement conditions are of crucial importance for pharmaceutical entrepreneurs.

Please find out more about EUCOPE under About us.

EUCOPE in the News

EUCOPE is in regular contact with the press on current developments in the EU and national pharma markets.

Please find some examples here.